1361 related articles for article (PubMed ID: 12672737)
21. [Statins and muscular side-effects].
Brosteaux C; Ruiz J; Buclin T; Kuntzer T; Rodondi N
Rev Med Suisse; 2010 Mar; 6(239):510, 512-4, 516-7. PubMed ID: 20373698
[TBL] [Abstract][Full Text] [Related]
22. Muscle symptoms associated with statins: a series of twenty patients.
Soininen K; Niemi M; Kilkki E; Strandberg T; Kivistö KT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):51-4. PubMed ID: 16433891
[TBL] [Abstract][Full Text] [Related]
23. Statin myopathy.
Radcliffe KA; Campbell WW
Curr Neurol Neurosci Rep; 2008 Jan; 8(1):66-72. PubMed ID: 18367041
[TBL] [Abstract][Full Text] [Related]
24. Necrotizing Autoimmune myopathy: A case report on statin induced rhabdomyolysis requiring immunosuppressive therapy.
Kunwar S; Parekh JD; Chilukuri RS; Andukuri VA
Drug Discov Ther; 2018; 12(5):315-317. PubMed ID: 30464165
[TBL] [Abstract][Full Text] [Related]
25. The role of mitochondria in statin-induced myopathy.
Apostolopoulou M; Corsini A; Roden M
Eur J Clin Invest; 2015 Jul; 45(7):745-54. PubMed ID: 25991405
[TBL] [Abstract][Full Text] [Related]
26. Statin safety: lessons from new drug applications for marketed statins.
Jacobson TA
Am J Cardiol; 2006 Apr; 97(8A):44C-51C. PubMed ID: 16581328
[TBL] [Abstract][Full Text] [Related]
27. Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction.
Kind AH; Zakowski LJ; McBride PE
WMJ; 2002; 101(7):53-6. PubMed ID: 12426921
[TBL] [Abstract][Full Text] [Related]
28. [Myotoxicity and rhabdomyolisis due to statins].
Banga JD
Ned Tijdschr Geneeskd; 2001 Dec; 145(49):2371-6. PubMed ID: 11770264
[TBL] [Abstract][Full Text] [Related]
29. Managing statin-induced muscle toxicity in a lipid clinic.
Blaier O; Lishner M; Elis A
J Clin Pharm Ther; 2011 Jun; 36(3):336-41. PubMed ID: 21414023
[TBL] [Abstract][Full Text] [Related]
30. Statin-associated autoimmune myopathy and anti-HMGCR autoantibodies.
Mohassel P; Mammen AL
Muscle Nerve; 2013 Oct; 48(4):477-83. PubMed ID: 23519993
[TBL] [Abstract][Full Text] [Related]
31. [Adverse effects of statins].
Andréjak M; Gras V; Massy ZA; Caron J
Therapie; 2003; 58(1):77-83. PubMed ID: 12822204
[TBL] [Abstract][Full Text] [Related]
32. Muscle aches and pains from statin use. Discomfort usually resolves with a lower dose or a different statin.
Harv Heart Lett; 2012 Oct; 23(2):5. PubMed ID: 23437465
[No Abstract] [Full Text] [Related]
33. Suggested clinical approach for the diagnosis and management of 'statin intolerance' with an emphasis on muscle-related side-effects.
Sivashanmugarajah A; Fulcher J; Sullivan D; Elam M; Jenkins A; Keech A
Intern Med J; 2019 Sep; 49(9):1081-1091. PubMed ID: 31507054
[TBL] [Abstract][Full Text] [Related]
34. Is there value in liver function test and creatine phosphokinase monitoring with statin use?
Sniderman AD
Am J Cardiol; 2004 Nov; 94(9A):30F-34F. PubMed ID: 15519289
[TBL] [Abstract][Full Text] [Related]
35. Outcomes in 45 patients with statin-associated myopathy.
Hansen KE; Hildebrand JP; Ferguson EE; Stein JH
Arch Intern Med; 2005 Dec 12-26; 165(22):2671-6. PubMed ID: 16344427
[TBL] [Abstract][Full Text] [Related]
36. Statin-induced apoptosis and skeletal myopathy.
Dirks AJ; Jones KM
Am J Physiol Cell Physiol; 2006 Dec; 291(6):C1208-12. PubMed ID: 16885396
[TBL] [Abstract][Full Text] [Related]
37. Statins and myotoxicity: a therapeutic limitation.
Tiwari A; Bansal V; Chugh A; Mookhtiar K
Expert Opin Drug Saf; 2006 Sep; 5(5):651-66. PubMed ID: 16907655
[TBL] [Abstract][Full Text] [Related]
38. Presymptomatic neuromuscular disorders disclosed following statin treatment.
Tsivgoulis G; Spengos K; Karandreas N; Panas M; Kladi A; Manta P
Arch Intern Med; 2006 Jul; 166(14):1519-24. PubMed ID: 16864763
[TBL] [Abstract][Full Text] [Related]
39. Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors.
Jamal SM; Eisenberg MJ; Christopoulos S
Am Heart J; 2004 Jun; 147(6):956-65. PubMed ID: 15199341
[TBL] [Abstract][Full Text] [Related]
40. The relationship of vitamin D deficiency to statin myopathy.
Gupta A; Thompson PD
Atherosclerosis; 2011 Mar; 215(1):23-9. PubMed ID: 21185021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]